Cellyan Biotechnology , Ltd Overview
Get informed when a big investor buys or sells
+ Follow-12.14%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Cellyan Biotechnology , Ltd posts a ROE of -12.14%. That is below the sector sector average of 11.85%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
For its sector stocks, a ROE near 11.85% is typical. Cellyan Biotechnology , Ltd's -12.14% is lower that level. That is roughly 202.4% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
Cellyan Biotechnology , Ltd's ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -12.14%; use YoY and peer views to separate noise from signal.
Context for HKPD's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 11.85%), and (3) consistency with growth and profitability. This page covers the first two; Cellyan Biotechnology , Ltd's other metric pages and overview cover the third.
